Responsive Playbooks and the CTVA Inflection
This article provides an in-depth analysis of Corteva Inc. (NASDAQ: CTVA) with strong bullish sentiment across all time horizons. It outlines distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with specific entry, target, and stop-loss levels. The piece also highlights support and resistance levels for near-term, mid-term, and long-term scenarios, emphasizing the stock's exceptional risk-reward short setup.
DuPont de Nemours Inc (LTS:0A6B) Stock Earnings Transcripts
This GuruFocus article provides a comprehensive list of earnings call and conference transcripts for DuPont de Nemours Inc (LTS:0A6B) dating back to 2018. It includes financial data such as market cap, enterprise value, and PE ratio. The page serves as a resource for investors looking to access historical public statements and financial discussions from the company.
Sen. Gary C. Peters Buys Shares of AT&T Inc. (NYSE:T)
Senator Gary C. Peters (Democratic-Michigan) recently purchased AT&T Inc. (NYSE:T) shares valued between $1,001 and $15,000 on June 29th, according to a July 2nd filing. This transaction follows AT&T's latest earnings beat with $0.57 EPS and $31.51 billion in revenue, along with a reaffirmed FY 2026 EPS guidance and a 5.4% dividend yield. Despite positive news like an expanded Build-A-Plan offering, the stock faces pressure from SpaceX/Starlink competition concerns and a recent analyst downgrade.
Price to sales forward of Corteva, Inc. – NYSE:CTVA
This article provides financial data for Corteva, Inc. (NYSE: CTVA), specifically its "Price to sales forward" metric. It appears to be a stub or data point from a financial platform, containing only the title and acknowledging the data source.
Does Integrating Arginex Soy Into Seed Treatments Deepen Corteva’s Biologicals Strategy (CTVA)?
Corteva, Inc. and Arevo AB have partnered to integrate Arginex Soy, an arginine-based seed treatment, into Corteva's soybean seed treatment portfolio. This move aims to enhance soybean resilience and nutrient efficiency, aligning with Corteva's strategy to expand its biologicals and innovation offerings. While supporting its long-term growth narrative, this partnership does not immediately alter the near-term risks associated with farmer economics or the complexities introduced by Corteva’s planned spin-off of its seed business.
Corteva and Arevo Partner on Soy Crop Nutrition
Corteva, a global agriculture company, and Arevo, a Swedish crop nutrition company, have announced a partnership to integrate Arevo's Arginex Soy, an arginine-based seed treatment, into Corteva's soybean seed treatment portfolio. This partnership aims to enhance soybean performance by strengthening root systems and improving nodulation, thus boosting yields and crop resilience through more sustainable practices. The agreement follows a multi-stage technical evaluation confirming Arginex Soy's agronomic benefits and compatibility with existing seed treatment processes.
This Senator Just Bought Up To $15K In AT&T Stock
Senator Gary C Peters recently purchased between $1,001 and $15,000 worth of AT&T (NYSE: T) stock on June 29, 2026. This transaction follows a pattern of active trading by the Senator, who has made 24 stock trades valued at over $136,000 in the past three years. Congressional transactions, while not a primary investment driver, can offer insights into the financial activities of lawmakers.
Corteva and Arevo Partner on Soy Crop Nutrition
Corteva and Arevo have partnered to integrate Arevo’s Arginex Soy, an arginine-based seed treatment, into Corteva’s soybean seed treatment portfolio. This partnership aims to improve nutrient use efficiency, strengthen root systems, and increase nodulation in soybeans for farmers in Europe. The product helps boost yields and crop resilience while supporting more sustainable production practices, following a rigorous technical evaluation confirming its performance and compatibility.
Corteva and Arevo Partner on Soy Crop Nutrition
Corteva and Arevo have announced a partnership to integrate Arevo’s Arginex Soy, an arginine-based seed treatment, into Corteva’s soybean seed treatment portfolio in Europe. This collaboration aims to help farmers improve nutrient use efficiency, strengthen root systems, and increase nodulation in soybeans. The partnership follows a rigorous technical evaluation confirming the product's effectiveness and compatibility with existing seed treatment processes.
Can the Blueberries Segment Accelerate Mission Produce's Growth?
Mission Produce's blueberry segment is poised to become a significant long-term growth driver, despite current challenges from newly planted acreage. The company views blueberries as a standalone opportunity and a way to optimize its global infrastructure by enabling year-round asset utilization with other crops like mangoes. Improved production efficiency and asset utilization are expected to enhance profitability and contribute to Mission Produce's diversified growth strategy.
Corteva and Arevo Partner on Soy Crop Nutrition
Corteva, a global agriculture company, and Arevo, a Swedish crop nutrition company, have partnered on Arginex Soy, an arginine-based seed treatment. This product strengthens root systems, increases nodulation, and improves soybean performance by enhancing nitrogen fixation and nutrient use efficiency. The partnership allows Corteva to integrate Arginex Soy into its European soybean seed treatment portfolio after a multi-stage technical evaluation confirmed its benefits and compatibility.
Bronte Capital Management Pty Ltd. Has $42.09 Million Stock Position in Corteva, Inc. $CTVA
Bronte Capital Management Pty Ltd. reduced its stake in Corteva, Inc. (NYSE:CTVA) by 11.6% in the first quarter but still holds 502,790 shares valued at $42.09 million, making it their 7th largest position. Corteva reported stronger-than-expected quarterly earnings with $1.50 EPS on $4.91 billion revenue, and analysts maintain a "Moderate Buy" rating with an average target price of $88.90. The company also declared a quarterly dividend of $0.18 per share.
BG - Bunge Global SA Options
This article provides comprehensive financial data for Bunge Global SA (BG), including its last close price, market capitalization, income, sales, dividend information, and various financial ratios like P/E, P/S, and Debt/Eq. It also details performance metrics such as EPS growth, insider and institutional ownership, and stock performance over different periods. The data is presented as of July 2nd, with the last close at 106.46, marking a 1.50% increase for the day.
CF - CF Industries Holdings Inc Options
This article provides a detailed financial overview of CF Industries Holdings Inc. (CF), including its stock performance, key financial ratios, earnings per share data, insider and institutional ownership, and dividend information. It also lists the company's peers and offers various performance metrics over different timeframes.
Mizuho Adjusts Price Target on Corteva to $96 From $94, Maintains Outperform Rating
Mizuho has increased its price target for Corteva (CTVA) to $96 from $94, while reiterating an "Outperform" rating on the stock. Corteva specializes in agricultural and phytosanitary products, with its net sales broken down into seed and grain production (56.9%) and crop protection products (43.1%). The company announced several recent corporate activities, including board changes and presentations at industry conferences.
CTVA - Corteva Inc Volatility & Greeks
This article provides a detailed financial overview of Corteva Inc (CTVA), including its stock performance, valuation metrics, income statement analysis, balance sheet ratios, and various key indicators like volatility and insider transactions. It highlights the company's current stock price, market capitalization, earnings, sales, and analyst recommendations, offering a comprehensive snapshot for investors.
NTR - Nutrien Ltd Options
This page provides a detailed financial overview of Nutrien Ltd (NTR), including its last close price, percentage change, and various financial metrics such as market capitalization, income, sales, and dividend information. It also presents key performance indicators, insider/institutional ownership, profitability ratios, and stock performance data across different timeframes, offering a comprehensive snapshot of the company's financial health and market activity.
Corteva Inc. stock outperforms competitors despite losses on the day
Shares of Corteva Inc. (CTVA) declined by 1.36% to $83.54 on Wednesday, breaking a 10-day winning streak, despite an overall tough trading session causing the S&P 500 and Dow Jones Industrial Average to also fall. Despite its own losses, Corteva's stock performance still managed to outperform its competitors, though details on competing stocks were not provided.
Corteva stock hits all-time high at 85.64 USD
Corteva Inc (CTVA) stock has reached an all-time high of $85.64, demonstrating a 27% surge over the past six months and a 10.77% increase over the last year. This achievement highlights investor confidence and the company's growth in the agricultural sector, though InvestingPro analysis suggests it may be overvalued. Recent positive news includes strong Q1 2026 financial results, a strategic agreement with FMC Corporation, and an reiterated "Overweight" rating from Morgan Stanley.
Farm Hands on the Potomac: Olivia Bridges joins Agri-Pulse team, Corteva announces boards of directors, Donna Garren appointed to FDA role
Olivia Bridges has been appointed as Agri-Pulse’s congressional and trade editor. Additionally, Corteva has revealed the new board of directors for its crop protection company, which will separate later this year. Donna Garren was also named the director of FDA’s Office of Produce Safety.
Corteva Inc. stock outperforms competitors on strong trading day
Shares of Corteva Inc. (CTVA) rose 1.58% to $84.69 on Tuesday, marking its tenth consecutive day of gains. The stock's performance outperformed the broader market, with the S&P 500 Index and Dow Jones Industrial Average also seeing increases on the favorable trading day.
CF Industries, Nutrien upgraded at Scotiabank on stabilizing fertilizer prices
Scotiabank has upgraded fertilizer producers CF Industries and Nutrien, citing stabilizing fertilizer prices and an attractive entry point for investors. Analyst Ben Isaacson believes that crop markets, fertilizer prices, and fertilizer equities are all nearing cyclical bottoms simultaneously. This positive outlook is driven by expected crop price increases, recovering fertilizer demand, potential weather disruptions, and compelling valuations.
Chemours Agrees to Controversial $452.5M Settlement Over PFAS Discharges
The Trump administration reached a $452.5 million settlement with Chemours Co. regarding unlawful discharges of PFAS "forever chemicals" in North Carolina, West Virginia, and New Jersey. This marks the first federal enforcement settlement against a PFAS maker, with Chemours facing a $22.5 million civil penalty and committing $90 million over 15 years to reduce PFAS discharges, including $280 million for clean drinking water near affected sites. The settlement, however, has drawn criticism from North Carolina's Attorney General, who called it "an insult" to the state's residents.
Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete to Resign from Corteva Board Ahead of Vylor Spin-Off
Four board members of Corteva, Karen Grimes, Marcos Lutz, Charles Magro, and Kerry Preete, will resign from their positions immediately before the company completes its spin-off of its seed business into Vylor. These individuals are expected to join the board of Vylor and their resignations are not due to any disagreements with Corteva.
Corteva (CTVA) details Corteva and Vylor boards as 4Q 2026 spin-off nears
Corteva Inc. (CTVA) is moving ahead with its plan to separate its seed business into a new, independent public company named Vylor Inc., with the spin-off targeted for the fourth quarter of 2026. The company officially announced the future board compositions for both Corteva and Vylor, with Greg Page chairing the post-separation Corteva board and Karen Grimes leading Vylor's board. Four current Corteva directors will transition to Vylor's board, and Vylor has filed its initial Form 10 registration statement with the SEC, detailing its business and financial information.
Corteva picks board for Vylor as seed spin-off stays on track for 4Q 2026
Corteva (NYSE:CTVA) has announced the initial board of directors for Vylor, its forthcoming advanced seed and genetics spin-off, with Karen Grimes appointed as independent chair. The seven-member board will become effective upon separation, which is still slated for Q4 2026. Vylor aims to leverage elite germplasm, biotech, gene editing, and molecular breeding to enhance its core seed businesses, expand into new row crops, and boost its licensing operations.
Corteva Announces Board of Directors for Future Crop Protection Company
Corteva Inc. (NYSE: CTVA) has announced its intended board of directors for its future standalone crop protection company, scheduled for separation in the fourth quarter of 2026. Greg Page will serve as Independent Chair of the nine-person board, with Luke Kissam appointed as the future CEO. The new company aims to be innovation-driven, focusing on operational efficiency, differentiated innovation, and leveraging nature-inspired technologies to benefit farmers and deliver shareholder value.
Corteva, Inc.(NYSE: CTVA) dropped from Russell 1000 Dynamic Index
Corteva, Inc. (NYSE: CTVA), a company specializing in agricultural and phytosanitary products, has been removed from the Russell 1000 Dynamic Index. This news comes amidst other recent developments for the company, including board changes, presentations at industry conferences, and collaborations with other firms like FMC Corporation. Analysts have also recently adjusted their price targets for Corteva.
Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
Corteva Inc. (NYSE: CTVA) has announced the board of directors for Vylor Inc., its upcoming advanced seed and genetics spin-off, which is on track for separation in the fourth quarter of 2026. Karen Grimes will serve as the Independent Chair of the board, bringing her extensive experience from Wellington Management Company LLP and IBM. Vylor aims to leverage its expertise in seed and genetics, including gene editing and molecular breeding, to address global agricultural challenges and deliver shareholder value.
Citigroup maintains Corteva (CTVA) neutral recommendation
Citigroup has reiterated its 'neutral' recommendation for Corteva (CTVA) in a recent analyst note.
Citigroup maintains Corteva (CTVA) neutral recommendation
Citigroup has reiterated its Neutral rating for Corteva (CTVA) with a price target of $58.00. This suggests that the analyst firm believes the stock will perform in line with the broader market.
FMC Corp. sells Delaware site for $114 million, shares steady on NYSE
FMC Corp. has agreed to sell a Delaware property for $114 million, a move aimed at focusing on its core crop protection business. The specialty chemicals group's shares continue to trade steadily on the NYSE. This sale is part of the company's strategy to streamline operations and reallocate capital towards its primary agrochemical portfolio, aligning with similar actions by peers like Corteva and Bayer Crop Science.
Enterprise value to EBIT forward of Corteva, Inc. – NYSE:CTVA
This article provides financial information for Corteva, Inc. (NYSE: CTVA), specifically its Enterprise Value to EBIT (Earnings Before Interest and Taxes) forward. It highlights various market data and resources available on the TradingView platform related to the company's financials, technicals, and forecasts. The content also lists numerous features and services offered by TradingView to investors and traders.
Enterprise value to EBIT forward of Corteva Inc – LS:A2PKRR
This article provides financial information for Corteva Inc (LS:A2PKRR), specifically focusing on its enterprise value to EBIT forward. It lists market status and directs users to various sections of financial data, news, and community discussions on its platform. The text is primarily a directory to data on TradingView for the specified stock.
How Investors May Respond To Corteva (CTVA) Rimisoxafen Supply Deal And US$200 Million Prepurchase
FMC Corporation and Corteva, Inc. announced a supply and license agreement for rimisoxafen herbicide technology, involving a US$200 million prepurchase commitment from Corteva. This deal strengthens Corteva's herbicide portfolio, though its impact is seen as a medium-term catalyst rather than an immediate change, with commercial launches expected by the end of the decade. Despite potential benefits, investors should consider risks like prolonged crop price weakness limiting Corteva's pricing power.
How Investors May Respond To Corteva (CTVA) Rimisoxafen Supply Deal And US$200 Million Prepurchase
Corteva, Inc. and FMC Corporation have entered a substantial supply and license agreement for FMC’s rimisoxafen herbicide technology, involving a US$200 million prepurchase commitment from Corteva. This deal enhances Corteva's weed-control portfolio and is seen as a medium-term product catalyst, not altering near-term risks like pricing pressure. Despite this, management reaffirmed its 2026 operating EPS guidance, signaling confidence in future growth while facing current margin pressures.
Corteva Inc. stock underperforms Friday when compared to competitors despite daily gains
Corteva Inc. (CTVA) shares rose 1.23% on Friday, despite an overall poor trading session for the stock market where the S&P 500 and Dow Jones Industrial Average both fell. This marked the eighth consecutive day of gains for Corteva's stock. However, compared to its competitors, Corteva underperformed.
Corteva Stock And Other Pesticide Names Getting Relief From Supreme Court Lawsuit Limits
A recent U.S. Supreme Court ruling limiting state-level pesticide lawsuits has significantly altered the risk profile for agricultural chemical stocks, particularly those involved with glyphosate and paraquat products. This legal clarity, which prioritizes federal rules over state warning labels, eases uncertainty for companies like FMC, Corteva, and Nufarm. For investors, this development could be as impactful as earnings or growth projections, potentially presenting new valuation opportunities in these stocks.
Price to earnings forward of Corteva, Inc. – NYSE:CTVA
This article provides financial information for Corteva, Inc. (NYSE: CTVA), focusing on its forward price-to-earnings ratio. It indicates that the company's financial data is sourced from FactSet Research Systems Inc. and CUSIP Database.
Price to sales forward of Corteva, Inc. – BOATS:CTVA
This article provides financial data specifically on the "Price to sales forward" for Corteva, Inc. (CTVA) as reported through the Blue Ocean Alternative Trade System (BOATS). It includes the period, value, change, and change percentage. The data is presented within the TradingView platform context, indicating its source and various related financial tools.
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Corteva Inc. (NYSE: CTVA) shares rose following a landmark 7-2 U.S. Supreme Court decision that ruled the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) blocks state-level "failure to warn" claims for pesticides. This decision is seen as a significant catalyst for Corteva, reducing its long-term legal liability and providing regulatory clarity. The stock is trading above its major trend gauges, with key resistance at $84.50 and support at $78.50.
CTVA Forecast — Price Target — Prediction for 2027
This article provides an in-depth forecast for Corteva, Inc. (CTVA) stock, including analyst price targets, past performance, and financial data. It highlights that 26 analysts offer ratings, with a 1-year price forecast of $89.67. The stock's current price is $82.62, and analysts predict a maximum of $100.00 and a minimum of $77.00 for its future price.
Price to earnings forward of Corteva, Inc. – BOATS:CTVA
This page provides financial information for Corteva, Inc. (CTVA), specifically focusing on its forward price-to-earnings ratio. It is hosted on the TradingView platform, which offers various financial tools and market data services.
Enterprise value to EBIT forward of Corteva, Inc. – BOATS:CTVA
This article provides financial information for Corteva, Inc. (CTVA), specifically focusing on its enterprise value to EBIT forward. It highlights that the data is presented by BOATS (Blue Ocean Alternative Trade System) and is derived from various financial data providers.
Price to book forward of Corteva, Inc. – NYSE:CTVA
This article provides financial information for Corteva, Inc. (NYSE: CTVA), specifically focusing on its forward price-to-book ratio. The content appears to be a stub or a section of a larger financial data page on TradingView, indicating that the value for this metric is displayed within the platform.
Corteva Inc. stock outperforms competitors on strong trading day
Shares of Corteva Inc. (CTVA) rose by 1.91% to $81.62, marking its seventh consecutive day of gains. This performance occurred on a mixed trading day, with the Dow Jones Industrial Average increasing and the S&P 500 Index slightly decreasing. The article highlights Corteva's strong individual stock performance relative to the broader market and its competitors.
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling
Corteva (NYSE: CTVA) shares are rising after a landmark 7-2 U.S. Supreme Court decision that provides a significant legal victory for the agricultural chemical sector. The ruling establishes a precedent that the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) preempts state-level "failure to warn" liability claims, shielding companies like Corteva from complex and costly state litigation. This decision is expected to lower long-term legal liability risks for Corteva and the broader crop protection industry.
Price to book forward of Corteva Inc – LS:A2PKRR
This article provides financial information for Corteva Inc (LS:A2PKRR), focusing on its price-to-book forward ratio. It highlights that the market was closed with no trades at the time of publication and directs users to various financial tools and data from TradingView and its partners.
Understanding the Setup: (CTVA) and Scalable Risk
This article analyzes Corteva Inc. (NASDAQ: CTVA), identifying a strong short-term sentiment potentially leading to a long-term positive bias. It highlights a 30.4:1 risk-reward setup, targeting an 8.9% gain against 0.3% risk, and provides three distinct AI-generated trading strategies for different risk profiles. The analysis includes position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis.
Enterprise value to revenue forward of Corteva Inc – LS:A2PKRR
This article focuses on the "Enterprise value to revenue forward" metric for Corteva Inc (LS:A2PKRR). It appears to be a financial data page from TradingView, providing an overview of Corteva's financial information within the context of agricultural commodities and milling. The content indicates market data and financial details are provided by various sources like ICE Data Services and FactSet.
